CN1399680A - 上皮细胞生长抑制剂 - Google Patents

上皮细胞生长抑制剂 Download PDF

Info

Publication number
CN1399680A
CN1399680A CN00811779A CN00811779A CN1399680A CN 1399680 A CN1399680 A CN 1399680A CN 00811779 A CN00811779 A CN 00811779A CN 00811779 A CN00811779 A CN 00811779A CN 1399680 A CN1399680 A CN 1399680A
Authority
CN
China
Prior art keywords
cell
ecgi
breast
statin
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00811779A
Other languages
English (en)
Chinese (zh)
Inventor
P·R·小欧文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotherapies Inc
Original Assignee
Biotherapies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotherapies Inc filed Critical Biotherapies Inc
Publication of CN1399680A publication Critical patent/CN1399680A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN00811779A 1999-06-18 2000-06-19 上皮细胞生长抑制剂 Pending CN1399680A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13999599P 1999-06-18 1999-06-18
US60/139,995 1999-06-18

Publications (1)

Publication Number Publication Date
CN1399680A true CN1399680A (zh) 2003-02-26

Family

ID=22489251

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00811779A Pending CN1399680A (zh) 1999-06-18 2000-06-19 上皮细胞生长抑制剂

Country Status (13)

Country Link
EP (1) EP1190054A1 (pt)
JP (1) JP2003513615A (pt)
KR (1) KR20020016837A (pt)
CN (1) CN1399680A (pt)
AU (1) AU783373B2 (pt)
BR (1) BR0012301A (pt)
CA (1) CA2375498A1 (pt)
IL (1) IL147148A0 (pt)
MX (1) MXPA01013242A (pt)
NZ (1) NZ516545A (pt)
PL (1) PL352997A1 (pt)
WO (1) WO2000078955A1 (pt)
ZA (1) ZA200200145B (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107142237A (zh) * 2011-05-17 2017-09-08 李晖 培养基、细胞培养用试剂盒及细胞培养方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500937B1 (en) 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor
US6342533B1 (en) 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
WO2001098496A1 (en) * 2000-06-19 2001-12-27 The University Of Michigan Mammastatin sequence variant c

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031625A1 (en) * 1995-04-07 1996-10-10 Cytogen Corporation Polypeptides having a functional domain of interest and methods of identifying and using same
EP0929675A2 (en) * 1996-10-03 1999-07-21 Biotherapies, Inc. Nucleotide and protein sequence of mammastatin and methods of use
US6500937B1 (en) * 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107142237A (zh) * 2011-05-17 2017-09-08 李晖 培养基、细胞培养用试剂盒及细胞培养方法

Also Published As

Publication number Publication date
WO2000078955A1 (en) 2000-12-28
MXPA01013242A (es) 2002-11-04
CA2375498A1 (en) 2000-12-28
JP2003513615A (ja) 2003-04-15
AU783373B2 (en) 2005-10-20
IL147148A0 (en) 2002-08-14
NZ516545A (en) 2004-06-25
BR0012301A (pt) 2002-03-26
KR20020016837A (ko) 2002-03-06
WO2000078955A9 (en) 2002-09-06
AU6052300A (en) 2001-01-09
ZA200200145B (en) 2003-04-30
PL352997A1 (en) 2003-09-22
EP1190054A1 (en) 2002-03-27

Similar Documents

Publication Publication Date Title
CN1141059A (zh) P53-结合多肽和编码该多肽的多核苷酸
CN1189482C (zh) 一种新的血管发生抑制剂
CN1399680A (zh) 上皮细胞生长抑制剂
CN1234728C (zh) 新的人淋巴因子、其编码序列及用途
CN1244595C (zh) 一种肿瘤抑制蛋白及其应用
CN1296974A (zh) 一种新的多肽——人组蛋白h2a.21和编码这种多肽的多核苷酸
CN1289524C (zh) 一种人端粒酶活性抑制蛋白及其应用
CN1704426A (zh) 一种癌症基因及其医药用途
CN1169832C (zh) 基因p28－II的鉴定与功能研究
CN100335620C (zh) 人胆固醇酯合成酶－2b及其编码序列
CN1345851A (zh) 一种新的多肽——人含组蛋白h3特征序列片段的蛋白11.66和编码这种多肽的多核苷酸
CN1297923A (zh) 一种新的多肽——人含细胞色素c结构域的脂蛋白105和编码这种多肽的多核苷酸
CN1517362A (zh) 一种新的多肽——人含atp/gtp结合结构域的核糖体蛋白s9和编码这种多肽的多核苷酸
CN1381567A (zh) 一种多肽——丝氨酸羟甲基转移酶－10.56和编码这种多肽的多核苷酸
CN1534043A (zh) 人骨髓基质细胞来源的泛素样分子及其编码序列和用途
CN1393549A (zh) 一种多肽——胰蛋白酶原－26.51和编码这种多肽的多核苷酸
CN1315566A (zh) 一种新的多肽——人atp依赖的丝氨酸蛋白水解酶52和编码这种多肽的多核苷酸
CN1315569A (zh) 一种新的多肽——人atp依赖的丝氨酸蛋白水解酶11.3和编码这种多肽的多核苷酸
CN1618958A (zh) 人胆固醇酯合成酶－2c及其编码序列
CN1315567A (zh) 一种新的多肽——人atp依赖的丝氨酸蛋白水解酶10和编码这种多肽的多核苷酸
CN1493583A (zh) 一种新的多肽－人糖蛋白42和编码这种多肽的多核苷酸
CN1493584A (zh) 一种新的多肽－人肿瘤抑制因子46和编码这种多肽的多核苷酸
HK1115757A (en) A thymus-specific protein
CN1376707A (zh) 一种多肽——人锌指蛋白－35.09和编码这种多肽的多核苷酸
CN1345934A (zh) 一种新的多肽——含有dna聚合酶x家族特征的蛋白10.56和编码这种多肽的多核苷酸

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned